Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ja-Der Liang

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2023
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trialJeong Heo, Ja-Der Liang, Chang Won Kim, et al.
Pharmacological Research|January 9, 2023
In situ vaccination followed by intramuscular poly-ICLC injections for the treatment of hepatocellular carcinoma in mouse modelsMeng-Tzu Weng, Shih-Feng Yang, Shin-Yun Liu, et al.
Liver Cancer|January 7, 2016
Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)Bang-Bin Chen, Takamichi Murakami, Tiffany Ting-Fang Shih, et al.
Journal of Hepatology|March 14, 2020
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinomaNalee Kim, Jason Cheng, Inkyung Jung, et al.
Journal of Hepatology|September 14, 2020
Corrigendum to: "Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma" [J Hepatol (2020) 121-129]Nalee Kim, Jason Cheng, Inkyung Jung, et al.
Journal of Hepatocellular Carcinoma|June 19, 2025
In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular CarcinomaJa-Der Liang, Po-Chin Liang, Chia-Tung Shun, et al.
Cancer Letters|April 23, 2023
Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinomaShih-Feng Yang, Meng-Tzu Weng, Ja-Der Liang, et al.
Abdominal Radiology (New York)|June 17, 2021
Prospective assessment of diagnostic efficacy and safety of Sonazoid<sup>TM</sup> and SonoVue<sup>®</sup> ultrasound contrast agents in patients with focal liver lesionsKe Lv, Hongyan Zhai, Yuxin Jiang, et al.
Journal of Medical Ultrasound|September 3, 2020
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using SonazoidJae Young Lee, Yasunori Minami, Byung Ihn Choi, et al.
Ultrasonography (Seoul, Korea)|May 26, 2020
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using SonazoidJae Young Lee, Yasunori Minami, Byung Ihn Choi, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2023
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trialJeong Heo, Ja-Der Liang, Chang Won Kim, et al.
Pharmacological Research|January 9, 2023
In situ vaccination followed by intramuscular poly-ICLC injections for the treatment of hepatocellular carcinoma in mouse modelsMeng-Tzu Weng, Shih-Feng Yang, Shin-Yun Liu, et al.
Liver Cancer|January 7, 2016
Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)Bang-Bin Chen, Takamichi Murakami, Tiffany Ting-Fang Shih, et al.
Journal of Hepatology|March 14, 2020
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinomaNalee Kim, Jason Cheng, Inkyung Jung, et al.
Journal of Hepatology|September 14, 2020
Corrigendum to: "Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma" [J Hepatol (2020) 121-129]Nalee Kim, Jason Cheng, Inkyung Jung, et al.
Journal of Hepatocellular Carcinoma|June 19, 2025
In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular CarcinomaJa-Der Liang, Po-Chin Liang, Chia-Tung Shun, et al.
Cancer Letters|April 23, 2023
Neoantigen vaccination augments antitumor effects of anti-PD-1 on mouse hepatocellular carcinomaShih-Feng Yang, Meng-Tzu Weng, Ja-Der Liang, et al.
Abdominal Radiology (New York)|June 17, 2021
Prospective assessment of diagnostic efficacy and safety of Sonazoid<sup>TM</sup> and SonoVue<sup>®</sup> ultrasound contrast agents in patients with focal liver lesionsKe Lv, Hongyan Zhai, Yuxin Jiang, et al.
Journal of Medical Ultrasound|September 3, 2020
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using SonazoidJae Young Lee, Yasunori Minami, Byung Ihn Choi, et al.
Ultrasonography (Seoul, Korea)|May 26, 2020
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using SonazoidJae Young Lee, Yasunori Minami, Byung Ihn Choi, et al.
Pageof 3